BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2465070)

  • 1. Enantiomer selectivity and the development of tolerance to the behavioral effects of the calcium channel activator BAY K 8644.
    O'Neill SK; Bolger GT
    Brain Res Bull; 1988 Dec; 21(6):865-72. PubMed ID: 2465070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative behavioral, neurochemical and pharmacological activities of dihydropyridine calcium channel activating drugs.
    O'Neill SK; McKay DW; Campbell N; Triggle CR; Crowley M; Bolger GT
    J Pharmacol Exp Ther; 1990 Jun; 253(3):905-12. PubMed ID: 1694243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dihydropyridine Ca2+ channel blockers on the discriminative stimulus and the motor impairing effects of (+/-)-Bay K 8644.
    Cohen C; Perrault G; Sanger DJ
    Eur J Pharmacol; 1997 Oct; 336(2-3):113-21. PubMed ID: 9384222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The behavioral effects of the calcium agonist Bay K 8644 in the mouse: antagonism by the calcium antagonist nifedipine.
    Bolger GT; Weissman BA; Skolnick P
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):373-7. PubMed ID: 2581145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competitive binding experiments reveal differential interactions for dihydropyridine calcium channel activators and antagonists at dihydropyridine receptors on mouse brain membranes.
    O'Neill SK; Triggle CR; Bolger GT
    Can J Physiol Pharmacol; 1994 Jul; 72(7):738-45. PubMed ID: 7530159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of strychnine on the regulation of voltage-dependent calcium channels by dihydropyridines in brain and heart.
    O'Neill SK; Bolger GT
    Pharmacol Biochem Behav; 1990 Apr; 35(4):833-40. PubMed ID: 1693213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of protein kinase C by 1,4-dihydro-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)-phenyl]-3-py rid ine carboxylic acid methyl ester (Bay K 8644), a calcium channel agonist, in alveolar type II cells.
    Sen N; Wu AM; Spitzer AR; Chander A
    Biochem Pharmacol; 1997 May; 53(9):1307-13. PubMed ID: 9214691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered behavioral sensitivity of Ca(2+)-modulating drugs after chronic nicotine administration in mice.
    Damaj MI
    Eur J Pharmacol; 1997 Mar; 322(2-3):129-35. PubMed ID: 9098679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular mechanical consequences of dihydropyridine calcium channel modulation in conscious and anesthetized chronically instrumented dogs.
    Pagel PS; Hettrick DA; Warltier DC
    Anesthesiology; 1994 Jul; 81(1):190-208. PubMed ID: 7519000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAY K 8644 enhances immobility in the mouse behavioral despair test, an effect blocked by nifedipine.
    Mogilnicka E; Czyrak A; Maj J
    Eur J Pharmacol; 1988 Jul; 151(2):307-11. PubMed ID: 2458947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric interactions at L-type calcium channels between FPL 64176 and the enantiomers of the dihydropyridine Bay K 8644.
    Usowicz MM; Gigg M; Jones LM; Cheung CW; Hartley SA
    J Pharmacol Exp Ther; 1995 Nov; 275(2):638-45. PubMed ID: 7473149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of dihydropyridine calcium channel modulators on pentylenetetrazole convulsions.
    O'Neill SK; Bolger GT
    Brain Res Bull; 1990 Jul; 25(1):211-4. PubMed ID: 1698518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The calcium channel agonist BAY k 8644 reduces ethanol intake and preference in alcohol-preferring AA rats.
    de Beun R; Schneider R; Klein A; Lohmann A; Schreiber R; De Vry J
    Psychopharmacology (Berl); 1996 Oct; 127(4):302-10. PubMed ID: 8923564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of neurotransmitter metabolism by dihydropyridine calcium channel ligands in mouse brain.
    Bolger GT; Lesieur P; Basile AS; Skolnick P
    Brain Res; 1988 Jan; 438(1-2):101-7. PubMed ID: 2449929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel 'agonist' BAY K 8644 inhibits calcium antagonist binding to brain and PC12 cell membranes.
    Greenberg DA; Cooper EC; Carpenter CL
    Brain Res; 1984 Jul; 305(2):365-8. PubMed ID: 6204725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 1,4-dihydropyridine (Bay K 8644) facilitates calcium-dependent [3H]noradrenaline release from PC 12 cells.
    Albus U; Habermann E; Ferry DR; Glossmann H
    J Neurochem; 1984 Apr; 42(4):1186-9. PubMed ID: 6199462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the effects of (-) and (+) isomers of the 1,4-dihydropyridine calcium channel agonist BAY k 8644 on postrest potentiation in the canine ventricular muscle.
    Saha JK; Hryshko LV; Bouchard RA; Chau T; Bose D
    Can J Physiol Pharmacol; 1989 Jul; 67(7):788-94. PubMed ID: 2475236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydropyridine agonist Bay K 8644 inhibits platelet activation by competitive antagonism of thromboxane A2-prostaglandin H2 receptor.
    Johnson GJ; Dunlop PC; Leis LA; From AH
    Circ Res; 1988 Mar; 62(3):494-505. PubMed ID: 2449295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two calcium channels in basolateral membranes of rabbit ileal epithelial cells.
    Homaidan FR; Donowitz M; Weiland GA; Sharp GW
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G86-93. PubMed ID: 2473655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Single channel analysis of Ca2+ channel-agonistic action of dihydropyridine derivatives: voltage-dependent effects of YC-170 and BAY K 8644].
    Takeda Y
    Hokkaido Igaku Zasshi; 1993 Jul; 68(4):557-69. PubMed ID: 7687975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.